top of page

Biden’s SOTU Targets Drug Companies, But Misses Opportunity To Challenge Health Insurers And PBMs

President Biden’s State of the Union Address hammered home the point that drug prices must come down. He reminded viewers that he and his Democratic colleagues are doing something about the problem, as he touted the Inflation Reduction Act’s drug pricing provisions. Moreover, the President reproached pharmaceutical companies for making record profits from insulin, adding that he seeks to expand the $35 per month cap on out-of-pocket costs to the entire population, not just Medicare beneficiaries.


Komentáře


bottom of page